Provision of new cardiomyocyte progenitor cells and cardiomyocytes derived therefrom

Details for Australian Patent Application No. 2008204541 (hide)

Owner Lead Pharma Holding B.V.

Inventors Doevendans, Pieter; Goumans, Marie Jose

Agent Spruson & Ferguson

Pub. Number AU-A-2008204541

PCT Pub. Number WO2008/083962

Priority EP07000374.4 09.01.07 EP; EP08000174.6 07.01.08 EP

Filing date 9 January 2008

Wipo publication date 17 July 2008

International Classifications

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/34 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Muscles

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/083962 Priority application(s): WO2008/083962

17 June 2010 Assignment before Grant

  Lead Pharma Holding B.V. The application has been assigned to Lead Pharma Cel Models IP B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008204546-Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid

2008204534-Synthesis